Work

Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA{middle dot}CER) trial

Year: 2013

Type: article

Source: European Heart Journal

DOI: 10.1093/eurheartj/eht104

Authors: S. Leonardi, P. Tricoci, H. D. White, P. W. Armstrong, Z. Huang, L. Wallentin, P. E. Aylward, D. J. Moliterno, F. Van de Werf, E. Chen, L. Providencia, J. E. Nordrehaug, C. Held, J. Strony, T. L. Rorick, R. A. Harrington, K. W. Mahaffey

Institutions: Duke Clinical Research Institute, Green Lane Hospital, University of Alberta, Uppsala University, Flinders Medical Centre, University of Kentucky, KU Leuven, Merck & Co., Inc., Rahway, NJ, USA (United States), Unidade Local de Saúde de Coimbra, University of Bergen, Stanford University

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2142004106

FWCI: 5.463

Cites: 22

Cited by: 37

Related to: 10